MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 116, Issue 9, Pages 2061-2073
Publisher
Wiley
Online
2015-03-21
DOI
10.1002/jcb.25162
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coordinated Targeting of the EGFR Signaling Axis by MicroRNA-27a*
- (2015) Xiaoli Wu et al. Oncotarget
- MicroRNA profile in very young women with breast cancer
- (2014) Maria Peña-Chilet et al. BMC CANCER
- Downregulation of miR-21 Enhances Chemotherapeutic Effect of Taxol in Breast Carcinoma Cells
- (2014) Mei Mei et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Therapeutic Potential of an Anti-diabetic Drug, Metformin: Alteration of miRNA expression in Prostate Cancer Cells
- (2013) Cigir Biray Avci et al. Asian Pacific Journal of Cancer Prevention
- MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2)
- (2013) Xuyang Jiao et al. BREAST CANCER RESEARCH AND TREATMENT
- The miR-106b∼25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300
- (2013) Y Zhou et al. CELL DEATH AND DIFFERENTIATION
- The Function Role of miR-181a in Chemosensitivity to Adriamycin by Targeting Bcl-2 in Low-Invasive Breast Cancer Cells
- (2013) Ying Zhu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Identification of Prognosis-Relevant Subgroups in Patients with Chemoresistant Triple-Negative Breast Cancer
- (2013) K.-D. Yu et al. CLINICAL CANCER RESEARCH
- miR-222 and miR-29a contribute to the drug-resistance of breast cancer cells
- (2013) Shanliang Zhong et al. GENE
- Modulation of Cancer Traits by Tumor Suppressor microRNAs
- (2013) Ioannis Grammatikakis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MicroRNA-Regulated Protein-Protein Interaction Networks and Their Functions in Breast Cancer
- (2013) Chia-Hsien Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth
- (2013) Suvi-Katri Leivonen et al. Molecular Oncology
- MicroRNA-21-3p, a Berberine-Induced miRNA, Directly Down-Regulates Human Methionine Adenosyltransferases 2A and 2B and Inhibits Hepatoma Cell Growth
- (2013) Ting-Fang Lo et al. PLoS One
- Down-Regulation of miR-183 Promotes Migration and Invasion of Osteosarcoma by Targeting Ezrin
- (2012) Junfeng Zhu et al. AMERICAN JOURNAL OF PATHOLOGY
- Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
- (2012) F. Andre et al. ANNALS OF ONCOLOGY
- Triple-negative breast cancer: epidemiological considerations and recommendations
- (2012) P. Boyle ANNALS OF ONCOLOGY
- Adjuvant treatments for triple-negative breast cancers
- (2012) H. Joensuu et al. ANNALS OF ONCOLOGY
- MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications
- (2012) Wei Tian et al. Clinical & Translational Oncology
- MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulatingGLUT3expression
- (2012) Xiang Fei et al. FEBS LETTERS
- Contribution of MicroRNA-1275 to Claudin11 Protein Suppression via a Polycomb-mediated Silencing Mechanism in Human Glioma Stem-like Cells
- (2012) Keisuke Katsushima et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways
- (2012) Ioannis S. Vlachos et al. NUCLEIC ACIDS RESEARCH
- Differential Expression of miRNAs in Colorectal Cancer: Comparison of Paired Tumor Tissue and Adjacent Normal Mucosa Using High-Throughput Sequencing
- (2012) Julian Hamfjord et al. PLoS One
- Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
- (2012) Hongjiang Wang et al. PLoS One
- Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells
- (2011) F. Kuchenbauer et al. BLOOD
- Adjuvant systemic treatment for individual patients with triple negative breast cancer
- (2011) Catherine Oakman et al. BREAST
- miRNA-34a is associated with docetaxel resistance in human breast cancer cells
- (2011) L. Kastl et al. BREAST CANCER RESEARCH AND TREATMENT
- Translational Control of TOP2A Influences Doxorubicin Efficacy
- (2011) S. Srikantan et al. MOLECULAR AND CELLULAR BIOLOGY
- Directed Therapy of Subtypes of Triple-Negative Breast Cancer
- (2011) L. A. Carey ONCOLOGIST
- Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype
- (2010) Seong Yoon Yi et al. BMC CANCER
- Management of triple negative breast cancer
- (2010) Catherine Oakman et al. BREAST
- The miR-17-92 Cluster of MicroRNAs Confers Tumorigenicity by Inhibiting Oncogene-Induced Senescence
- (2010) L. Hong et al. CANCER RESEARCH
- Treatment of triple negative breast cancer (TNBC): current options and future perspectives
- (2010) M. De Laurentiis et al. CANCER TREATMENT REVIEWS
- Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
- (2010) Igor P. Pogribny et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
- (2010) Ming Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 5-fluorouracil drug alters the microrna expression profiles in MCF-7 breast cancer cells
- (2010) Maitri Y. Shah et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MicroRNA 92a-2*: A Biomarker Predictive for Chemoresistance and Prognostic for Survival in Patients with Small Cell Lung Cancer
- (2010) Aarati R. Ranade et al. Journal of Thoracic Oncology
- Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
- (2010) Bo Song et al. Molecular Cancer
- Context-Dependent Bidirectional Regulation of the MutS Homolog 2 by Transforming Growth Factor Contributes to Chemoresistance in Breast Cancer Cells
- (2010) Y. Yu et al. MOLECULAR CANCER RESEARCH
- MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
- (2010) X Rao et al. ONCOGENE
- Widespread regulatory activity of vertebrate microRNA* species
- (2010) J.-S. Yang et al. RNA
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- microRNA-205 Regulates HER3 in Human Breast Cancer
- (2009) M. V. Iorio et al. CANCER RESEARCH
- Conserved MicroRNA miR-8/miR-200 and Its Target USH/FOG2 Control Growth by Regulating PI3K
- (2009) Seogang Hyun et al. CELL
- MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
- (2009) Richard Hummel et al. EUROPEAN JOURNAL OF CANCER
- Hyaluronan-CD44 Interaction with Protein Kinase Cϵ Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells
- (2009) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin
- (2009) Guo-Qing Chen et al. MEDICAL ONCOLOGY
- MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
- (2009) D. R. Cochrane et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNAs as New Players for Diagnosis, Prognosis, and Therapeutic Targets in Breast Cancer
- (2009) Enders K. O. Ng et al. Journal of Oncology
- Computational analysis of microRNA profiles and their target genes suggests significant involvement in breast cancer antiestrogen resistance
- (2008) Fuxiao Xin et al. BIOINFORMATICS
- Pattern of metastatic spread in triple-negative breast cancer
- (2008) Rebecca Dent et al. BREAST CANCER RESEARCH AND TREATMENT
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer
- (2008) Jian-Jun Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
- (2008) Cornelia Liedtke et al. JOURNAL OF CLINICAL ONCOLOGY
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- Endogenous human microRNAs that suppress breast cancer metastasis
- (2008) Sohail F. Tavazoie et al. NATURE
- An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer
- (2008) Kelly H. Salter et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started